DOSSIERS / CPO PHARMACEUTICALS LIMITED
← SearchExport PDF
Company dossier

CPO PHARMACEUTICALS LIMITED

CYPRUS · COMPANY · INCORPORATED 2000-04-01
KYBE ID: HE110329 · HE110329 · 1 sources
RISK SCORE60HIGH RISK
OverviewPeopleRisk signals 5Sources

Key facts

active
CPO PHARMACEUTICALS LIMITED
DRCIP data.gov.cy
HE110329
DRCIP data.gov.cy
active
DRCIP data.gov.cy
Private Company
DRCIP data.gov.cy
2000-04-01
DRCIP data.gov.cy
Βασιλέως Παύλου Α', 11,, 1096, Λευκωσία, Κύπρος
DRCIP data.gov.cy

Companies at this address

31 total
ARALIA ESTATES LIMITEDactiveBEAUTYSKIN ENTERPRISES LTDdissolvedCANOKA TRADING LIMITEDactiveCOSTAS A. PAPAELLINAS (MANUFACTURING) LIMITEDactiveCOSTAS PAPAELLINAS ESTATE LIMITEDdissolvedCOSTAS PAPAELLINAS ORGANIZATION LIMITEDactiveCPO COSTAS PAPAELLINASactiveCPO FOODSTUFF LIMITEDactiveCPO SCIENTRONICS LIMITEDactiveDISPOPHARM LIMITEDactiveGIOPAPA LIMITEDactiveHARMEN MEDICA LIMITEDdissolvedKERAVNOS SPORTING LIMITEDactivePAPEL COSMETICS LIMITEDactivePAP PHARMACY FIVE LIMITEDactivePAP PHARMACY FOUR LIMITEDactivePAP PHARMACY LAR 1 LIMITEDactivePAP PHARMACY LIM 2 LIMITEDactivePAP PHARMACY ONE LIMITEDactivePAP PHARMACY THREE LIMITEDactive

+11 more

People with significant control

4 people
NameRoleFromSource
ΓΙΩΡΓΟΣ ΠΑΠΑΕΛΛΗΝΑΣdirector—Cyprus registry
ΠΑΝΑΓΙΩΤΗΣ ΒΑΣΙΛΕΙΟΥdirector—Cyprus registry
ΠΑΡΙΣ ΠΑΠΑΕΛΛΗΝΑΣdirector—Cyprus registry
ΑΝΔΡΕΑΣ ΑΔΑΜΙΔΗΣsecretary—Cyprus registry

Risk signals

5 matched
low

Clustered address

Address shared by 31 companies

high

Single-bidder procurement pattern

15 of 16 public-tender wins had only ONE bidder (94%) — the classic bid-rigging / suppressed-competition signal

medium

Direct-award concentration

19 of 40 wins were direct awards with no open call for competition (negotiated-without-call / single-source) — a competition-bypass pattern

high

Business fragmentation

A director is shared across 58 companies — business-splitting (дробление) pattern

high

Phoenix predecessor

Shares a director with a failed, near-identically-named company (CHRISTOFIDES & PAPAELLINAS( PHARMACEUTICALS) LIMITED · dissolved · name-sim 0.49) — phoenixing pattern (shed debts under a new company)

Risk journey — why 60?

5 signals
+16
Single-bidder procurement pattern
+16
Business fragmentation
+15
Phoenix predecessor
+7
Direct-award concentration
+6
Clustered address
Composite risk score60/100